Liming Zhang

Liming Zhang

Auto-generated profile, based on publicly available information

Liming Zhang

Department of Dermatology, The First Hospital of China Medical University, National Health Commission Key Laboratory of Immunodermatology, Key Laboratory of Immunodermatology of Ministry of Education, Shenyang, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in BMC Medicine
Verified
Journal Article
Open access
PDF file
LZLiming Zhang
Liming Zhang
YWYuxiang Wang
Yuxiang Wang
LQLi Qiu
Li Qiu
JWJian Wu
Jian Wu
Background: Psoriasis has been linked to cardiovascular disease (CVD), including coronary artery disease (CAD), myocardial infarction (MI), and heart failure (HF). However, available studies regarding this relationship have shown inconsistent results. Therefore, in this report, we performed a comprehensive review of the literature to assess the effects of psoriasis on risk of these CVDs. Methods: A search of literature until 24 December 2021 was done in PubMed, the Cochrane Library, Web of Science, Google Scholar, and Embase. Within European and East Asian populations, meta-analyses of observational studies assessing correlations between psoriasis and various CVD risk factors were conducted. Mendelian randomization (MR) was then employed to assess the causative impact of genetic pre-disposition for psoriasis on these CVD risk factors. Results: The results of the meta-analyses indicated that, in both the European and East Asian populations, psoriasis was significantly linked to an elevated risk in the incidence of CAD (RR = 1.51, 95% confidence interval (CI): 1.04–2.18, p = 0.028 and RR = 1.91, 95% CI: 1.62–2.25, p < 0.001) and MI (RR = 1.23, 95% CI: 1.04–1.46, p = 0.017 and RR = 2.17, 95% CI: 1.44–3.28, p < 0.001). A positive genetic relationship of psoriasis with CAD was found in European individuals (IVW OR:1.03; 95% CI: 1.01–1.06, p = 0.005) and in East Asian individuals (IVW OR:1.18; 95% CI: 1.03–1.32, p = 0.031). We also established that psoriasis was causally linked with an elevated risk of MI (IVW OR:1.05; 95% CI: 1.01–1.09, p = 0.026) in the European population as determined using an MR approach. Moreover, our MR results were congruent with the null findings from the meta-analysis assessing associations of psoriasis with HF risk. Conclusions: This research work provides preliminary evidence that psoriasis and CVD have a common genetic origin and that targeted psoriasis treatment might improve cardiovascular outcomes. These results not only increase our knowledge of the genetic underpinnings linking a comorbidity of psoriasis with CVD but also suggests a novel approach for CVD prevention.

4 August 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
LZLiming Zhang
Liming Zhang
LQLi Qiu
Li Qiu
JWJian Wu
Jian Wu
YQYumeng Qi
Yumeng Qi
XGXinghua Gao
Xinghua Gao
TXTing Xiao
Ting Xiao

1 January 2022 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
LZLiming Zhang
Liming Zhang
LQLi Qiu
Li Qiu
JWJian Wu
Jian Wu
YQYumeng Qi
Yumeng Qi
HWHexiao Wang
Hexiao Wang
TXTing Xiao
Ting Xiao
Zhang L, et al. Allergy Asthma Immunol Res. 2022 Jan;14(1):131-142. https://doi.org/10.4168/aair.2022.14.1.131

11 January 2020 in Disease Markers
Verified
Journal Article
Open access
PDF file
LQLi Qiu
Li Qiu
LZLiming Zhang
Liming Zhang
RQRui-Qun Qi
Rui-Qun Qi
XGXinghua Gao
Xinghua Gao
HCHongduo Chen
Hongduo Chen
TXTing Xiao
Ting Xiao
Background. Bullous pemphigoid (BP) is a common T helper 2- (Th2-) dominated autoimmune blistering skin disease with significant mortality. MicroRNAs (miRNAs), which are endogenous noncoding RNA molecules, have been reported to be potential biomarkers for some autoimmune diseases; however, to date, there exist no reports on serum expression profiles of miRNAs in BP patients. Methods. A RNA quantitative PCR- (qPCR-) based array was conducted on sera from 20 active BP patients and 20 healthy controls for screening of miRNAs. Significantly dysregulated miRNAs were validated with use of qPCR as performed on sera samples of 45 active BP patients and 60 healthy controls. Serum CCL17, anti-BP180, and anti-BP230 levels were measured with use of ELISA. Results. Relative baseline expression levels of serum miR-1291 were significantly upregulated in the 45 BP patients as compared with the 60 healthy controls (P<0.001) and significantly decreased in the disease control stage (n=13, P=0.006). In addition, these baseline miR-1291 levels showed a significant positive correlation with the baseline levels of serum CCL17 (P<0.001) and anti-BP180 (n=38, P=0.024). Like that observed for miR-1291, baseline levels of serum CCL17 were also significantly elevated in the 45 BP patients compared with the 60 healthy controls (P<0.001) and significantly decreased in the disease control stage (n=13, P=0.002). However, for anti-BP180, baseline serum levels were significantly elevated in only 38 of the 45 BP patients and significantly decreased in the disease control stage (n=10, P=0.004). Conclusions. Relative expression levels of serum miR-1291 can reflect disease activity of BP. miR-1291 may function as an important new serum biomarker for BP.

29 March 2022 in Mechanisms of Ageing and Development
Verified
Journal Article
Closed access
LZLiming Zhang
Liming Zhang
WWWeijing Wang
Weijing Wang
CXChunsheng Xu
Chunsheng Xu
HDHai-Ping Duan
Hai-Ping Duan
XTXiaocao Tian
Xiaocao Tian
DZDongfeng Zhang
Dongfeng Zhang